# Hair relaxer & uterine cancer litigation

> Educational mass tort overview from DrugsMonitor.com. Not legal or medical advice.

**Canonical URL:** https://drugsmonitor.com/case/hair-relaxer-uterine-cancer-lawsuit
**Last updated:** 2026-06-11

## Key facts

- **Matter:** Hair Relaxer / Uterine Cancer
- **Status:** Discovery Phase
- **Scope:** United States — national overview
- **Drug safety page:** https://drugsmonitor.com/drug-info/hair-relaxer-uterine-cancer-lawsuit

## Overview

Hair-relaxer litigation alleges that chemical straightening products marketed to women—often containing endocrine-disrupting chemicals—are associated with uterine cancer, ovarian cancer, fibroids, and related gynecologic injuries in some long-term users.

### Science and public-health discussion

Epidemiologic studies and NIH-led research have reported associations between frequent use of hair straighteners and uterine cancer risk, prompting ongoing scientific debate about magnitude, confounding, and biological mechanism. Civil complaints translate those concerns into failure-to-warn and design theories against manufacturers.

Defendants challenge general causation and argue that many risk factors—genetics, obesity, other exposures—contribute to gynecologic disease. Courts eventually decide what expert testimony juries may hear.

### MDL structure and scale

Thousands of cases have been consolidated in the Northern District of Illinois. Large MDLs like this one involve shared discovery into formulation chemistry, marketing to Black women, toxicology, and internal company documents.

Individual plaintiffs typically retain separate claims; settlements, if any, are usually inventory-based rather than a single class judgment.

---

*DrugsMonitor.com is not a law firm. For medical decisions consult a licensed clinician; for legal decisions consult a qualified attorney.*